ZNTL

SEC source: 0001725160-23-000031 · wf-form4_167641965116508.xml · nonDerivative · entry 2

Bunker Kevin D. · CIK 0001807484 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 865,157

F3 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires July 31, 2023.

F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $19.73 to $20.29. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000035 · wf-form4_167641983783824.xml · nonDerivative · entry 2

Epperly Melissa B, · CIK 0001807359 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 392,048

F3 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires August 15, 2023.

F4 · balance_after: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $19.77 to $20.30. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000033 · wf-form4_167641974905249.xml · nonDerivative · entry 2

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 491,270

F3 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $19.73 to $20.30. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000031 · wf-form4_167641965116508.xml · nonDerivative · entry 1

Bunker Kevin D. · CIK 0001807484 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 871,657

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $19.79 to $20.64. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000035 · wf-form4_167641983783824.xml · nonDerivative · entry 1

Epperly Melissa B, · CIK 0001807359 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 397,275

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.

F2 · balance_after: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $19.79 to $20.64. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000033 · wf-form4_167641974905249.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 499,771

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $19.79 to $20.64. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000022 · wf-form4_167573016060449.xml · nonDerivative · entry 2

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 503,103

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $22.88 to $23.12. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000022 · wf-form4_167573016060449.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 503,675

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $21.77 to $22.76. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000020 · wf-form4_167529653658016.xml · derivative · entry 5

Bunker Kevin D. · CIK 0001807484 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,646

Underlying: Common Stock · 132,646 shares

Expires 2033-01-31

F3 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.

SEC source: 0001725160-23-000020 · wf-form4_167529653658016.xml · nonDerivative · entry 2

Bunker Kevin D. · CIK 0001807484 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 875,464

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.

SEC source: 0001725160-23-000015 · wf-form4_167529635221236.xml · derivative · entry 2

Brownstein Carrie · CIK 0001894232 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,687

Underlying: Common Stock · 23,687 shares

Expires 2033-01-31

F2 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.

SEC source: 0001725160-23-000015 · wf-form4_167529635221236.xml · nonDerivative · entry 1

Brownstein Carrie · CIK 0001894232 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,313

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.

SEC source: 0001725160-23-000016 · wf-form4_167529638915918.xml · derivative · entry 2

Paul Andrea · CIK 0001863130 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,217

Underlying: Common Stock · 59,217 shares

Expires 2033-01-31

F2 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.

SEC source: 0001725160-23-000016 · wf-form4_167529638915918.xml · nonDerivative · entry 1

Paul Andrea · CIK 0001863130 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,783

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.

SEC source: 0001725160-23-000018 · wf-form4_167529647568841.xml · derivative · entry 2

Blackwell Kimberly · CIK 0001816465 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,200

Underlying: Common Stock · 355,200 shares

Expires 2033-01-31

F2 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.

SEC source: 0001725160-23-000018 · wf-form4_167529647568841.xml · nonDerivative · entry 1

Blackwell Kimberly · CIK 0001816465 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,800

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.

SEC source: 0001725160-23-000017 · wf-form4_167529642722449.xml · derivative · entry 2

Epperly Melissa B, · CIK 0001807359 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,043

Underlying: Common Stock · 148,043 shares

Expires 2033-01-31

F3 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.

SEC source: 0001725160-23-000017 · wf-form4_167529642722449.xml · nonDerivative · entry 1

Epperly Melissa B, · CIK 0001807359 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,899

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.

F2 · balance_after: Includes 399 shares acquired under the Zentalis Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan on March 31, 2022.

SEC source: 0001725160-23-000019 · wf-form4_167529650576789.xml · derivative · entry 2

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,908

Underlying: Common Stock · 233,908 shares

Expires 2033-01-31

F2 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.

SEC source: 0001725160-23-000019 · wf-form4_167529650576789.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 513,103

F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.

SEC source: 0001725160-23-000008 · wf-form4_167408008586817.xml · nonDerivative · entry 2

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,011

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $24.78 to $24.93. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000008 · wf-form4_167408008586817.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,511

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.76 to $24.75. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000002 · wf-form4_167296417221057.xml · nonDerivative · entry 2

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 362,011

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $21.44 to $21.47. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000002 · wf-form4_167296417221057.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 362,311

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $20.39 to $21.35. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000202 · wf-form4_166855982730331.xml · nonDerivative · entry 2

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,011

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.21 to $23.57. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000202 · wf-form4_166855982730331.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,911

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $22.20 to $23.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-23-000020 · wf-form4_167529653658016.xml · nonDerivative · entry 1

Bunker Kevin D. · CIK 0001807484 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 784,110

SEC source: 0001725160-22-000194 · wf-form4_166795791845543.xml · nonDerivative · entry 3

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 384,511

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.18 to $23.94. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000194 · wf-form4_166795791845543.xml · nonDerivative · entry 2

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 396,885

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $24.22 to $24.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000194 · wf-form4_166795791845543.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 397,042

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.16 to $24.11. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000184 · wf-form4_166605490632481.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,385

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.00 to $23.96. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000182 · wf-form4_166517520562805.xml · nonDerivative · entry 3

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,885

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $22.20 to $23.11. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000182 · wf-form4_166517520562805.xml · nonDerivative · entry 2

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 431,885

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $22.47 to $23.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000182 · wf-form4_166517520562805.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 437,381

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $21.43 to $22.42. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000179 · wf-form4_166483672538571.xml · derivative · entry 4

Bunker Kevin D. · CIK 0001807484 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-10-02

F3 · derivative.exercise_date: The options were granted by the Issuer under the 2020 Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer.

SEC source: 0001725160-22-000179 · wf-form4_166483672538571.xml · nonDerivative · entry 1

Bunker Kevin D. · CIK 0001807484 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 814,110

F1 · shares: Represents restricted stock units ("RSUs") granted by the Issuer under the Zentalis Pharmaceuticals, Inc. 2020 Incentive Award Plan, as amended (the "2020 Plan"). The RSUs will vest over two years: 1/3 of the RSUs will vest on the first anniversary of the date of grant, and the remaining 2/3 of the RSUs will vest on the second anniversary of the date of grant.

SEC source: 0001725160-22-000178 · wf-form4_166483658913178.xml · derivative · entry 3

Brownstein Carrie · CIK 0001894232 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-10-02

F3 · derivative.exercise_date: The options were granted by the Issuer under the 2022 Inducement Plan as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest as to 100% of the shares on the earlier of (a) FDA approval of a Zentalis product or (b) a Change in Control (as defined in the 2022 Inducement Plan).

SEC source: 0001725160-22-000178 · wf-form4_166483658913178.xml · derivative · entry 2

Brownstein Carrie · CIK 0001894232 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2032-10-02

F2 · derivative.exercise_date: The options were granted by the Issuer under the 2022 Inducement Plan as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer.

SEC source: 0001725160-22-000178 · wf-form4_166483658913178.xml · nonDerivative · entry 1

Brownstein Carrie · CIK 0001894232 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

F1 · shares: Represents restricted stock units ("RSUs") granted by the Issuer under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (the "2022 Inducement Plan") as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years: 25% of the RSUs will vest on each of the first, second, third and fourth anniversaries of the date of grant.

SEC source: 0001725160-22-000180 · wf-form4_166483690075305.xml · nonDerivative · entry 1

Epperly Melissa B, · CIK 0001807359 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297,543

F1 · shares: Represents restricted stock units ("RSUs") granted by the Issuer under the 2020 Incentive Award Plan, as amended. The RSUs will vest over two years: 1/3 of the RSUs will vest on the first anniversary of the date of grant, and the remaining 2/3 of the RSUs will vest on the second anniversary of the date of grant.

F2 · balance_after: Includes 129 shares acquired under the Zentalis Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan on September 30, 2022.

SEC source: 0001725160-22-000167 · wf-form4_166337433049948.xml · nonDerivative · entry 4

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 444,385

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F5 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $24.84 to $25.12. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000167 · wf-form4_166337433049948.xml · nonDerivative · entry 3

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 445,519

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.83 to $24.78. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000167 · wf-form4_166337433049948.xml · nonDerivative · entry 2

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 454,385

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $25.39 to $25.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000167 · wf-form4_166337433049948.xml · nonDerivative · entry 1

Gallagher Cam · CIK 0001557832 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 458,459

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires June 5, 2023.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $24.39 to $25.38. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001725160-22-000165 · wf-form4_166298085835189.xml · nonDerivative · entry 1

Skvarka Jan · CIK 0001838042 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,606

F1 · shares: The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.

SEC source: 0001725160-22-000159 · wf-form4_166033599038928.xml · nonDerivative · entry 1

Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 95,000

F1 · kind: The sale reported in this Form 4 was effected pursuant to a plan that complies with Rule 10b5-1 and expires October 31, 2022.

F2 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.

SEC source: 0001725160-22-000142 · wf-form4_165938928345083.xml · derivative · entry 1

Paul Andrea · CIK 0001863130 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,500

Underlying: Common Stock · 290,500 shares

Expires 2032-07-31

F1 · derivative.exercise_date: The options were granted by the Issuer under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer.

SEC source: 0001725160-22-000135 · wf-form4_165836329544214.xml · nonDerivative · entry 1

Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 100,000

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021.

F2 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.

SEC source: 0001725160-22-000133 · wf-form4_165783821595135.xml · nonDerivative · entry 2

Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 105,000

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021.

F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $30.00 to $30.03. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.

SEC source: 0001725160-22-000133 · wf-form4_165783821595135.xml · nonDerivative · entry 1

Bunker Kevin D. · CIK 0001807484 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 108,290

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $30.00 to $30.06. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.